ÃâÒßѧÊÔÌâ
Ln#a<Rx.E7 Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
)+O r 1. Fas(CD95)/FasL
X.|Ygx 2. common chain of cytokine receptor
uf) Oy7FQ 3 . TCR/CD3 complex
L0h
G 4. negaive selection of thymocytes
!)OB@F%U 5. artificial active immune
-
HOnB= 6. anti-idiotypic
7$T8&Mh 7. IgSF
DR+,Y2!_GT 8. Integrin
+$beo2x6 9. chemokine
M[Y4_$k<- 10. B7/CD28
=q
CF%~ ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
,r+"7$ 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
JAb$M{t 2. ±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌص㡣
(ppoW 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆʵÑé·½°¸¿Ë¡´Ë»ùÒò¡£
]O{_O&w 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
#Q6w+" B\<ydN 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
6Dzs? P µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
IKm&xzV- Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
U~Q
MR-bz 1. B7/CD28
L{PH0Jf 2. Th1 subset
m6so]xr 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
Y1r,2 k 4. antibody affinity maturation
V/H@vKN2 5. AP-1
Zc\S$+PM 6. single chain variable fragment£¨ScFv£©
%h* 5xB]Tt 7. NK cell receptor
%Dyh:h 8. Zinkernagel-Doherty phenomenon
Ow3a0cF[9 9. Ig fold
xii$e 10. CD40/CD40L
IA4+ad'\E ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
XtW_ 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØϵ¡£
SI_?~Pf3k 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
V4?Oc2mS 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹Øϵ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
|BJqy/ Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
h6FgS9H 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁÜ°Íϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
;U
k!jQ
h 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
\\iK'|5YG 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æרҵ£©¡£
$[QcEk Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
+E#PJ_H=F8 £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
_S<?t9mS Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
\*9Ua/H 1.Co-stimulators (or co-stimulating molecules)
7kM4Ei 2.NK-kB
P' FKk< 3.Immunoglobulin superfamily
nk>8SW^ 4.antigen-presenting cell (APC)
UC#"=Xd4 5.death domain
yjv&4pIc1 6.CCR and CXCR
m9b(3 7.Lectin (or mitogen)
D?J#u;h~f 8.Clusters of differentiation, CD)
q-uLA&4 9.B7 family
.r*#OUC 10.Cytotoxic T lymphocyte, CTL)
F#^L9 11.IL-15 and IL-15 receptor (IL-15R)
,N;v~D$Y 12.MHC restriction
}(cY| 13.Affinity-chromatography
:4] J2U\@ 14.Cyctosprin A, CsA
vhNohCt 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
ip674'bq7R ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
J2=*-O: 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
7>KQRLw 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£
+|M{I= 8 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣
$BaK'7=3* Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
AW62~* ÃâÒßѧרҵ£º
`+Xe'ey 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
uYY=~o[
Tw Ïû»¯ÄÚ¿Æ£º
a6P
!Wzb 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
oM2|]ew) ѪҺ²¡Ñ§×¨Òµ£º
@,GjeF]! 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
M-vC>u3Y Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
%db3f
z (רҵ»ù´¡: ÃâÒßѧ)
E"ZEo9y@^ Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
srhFEmgN7) 1. ADCC(antibody dependent cell-mediated cytotoxicity)
DYkC'+TEX 2. »·æß¾úËØ(cyclosporin)
y3Y2QC(
3. KIR(killer cell inhibitory receptor)
2S'AIuIew 4. HLDA(human leucocyte differentiation antigen)
` v>/
5. Interleukin 18(IL-18)
i>WOYI9 6. ÕûºÏËØ(integrin)
j_(?=7Y3g 7. Fas/FasL
a4:`2 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
/%-
o.hT 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
oy`3r5g 10. Th1/Th2
.fbYB,0w 11. »ùÒòÒßÃç(DNAÒßÃç)
f>|9 l 12. chemokines and chemokine receptor
]X/O IfdWe 13. ÃâÒßÄÍÊÜ
<` #,AVH 14. ¹²´Ì¼¤·Ö×Ó
N&x@_t"" 15. ËÀÍö½á¹¹Óò(death domain)
1V#0\1sj ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
tP&{ J^G 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉË°Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
PpW
A
f\ 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»Æƶø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
q$bHO £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
)J{.Cx<E £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
aeLBaS £¨3£©1984Ä꣺ÁÜ°Íϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
[^h/(a` £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
6-D%)Z( 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄЩÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
e|S+G6 :O2 Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
6wa<'! ÎÊ´ðÌâ(ÿÌâ25·Ö)
.WxFm@]/\ 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
>ly&+3S 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
W
]a7&S 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆһϵͳʵÑé,¼ÓÒÔ֤ʵ¡£
y.L|rRe@P 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃÇ°¾°¡£